Eli Lilly Receivables 2010-2025 | LLY

Eli Lilly receivables for the quarter ending March 31, 2025 were $14.003B, a 39.84% increase year-over-year.

  • Eli Lilly receivables for 2024 were $13.275B, a 17.11% increase from 2023.
  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.

Eli Lilly Receivables 2010-2025 | LLY

  • Eli Lilly receivables for 2024 were $13.275B, a 17.11% increase from 2023.
  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$373.4B
AbbVie (ABBV)$329.2B
Novo Nordisk (NVO)$300.1B
Novartis AG (NVS)$252.8B
Roche Holding AG (RHHBY)$252.8B
Merck (MRK)$204.7B
Pfizer (PFE)$139.9B
Sanofi (SNY)$118B
Bayer (BAYRY)$31.1B
Innoviva (INVA)$1.3B